New England Hospice Ii, Llc in Hingham, Massachusetts

New England Hospice Ii, Llc is a medicare-certified hospice facility in Hingham, Massachusetts. It is a for profit hospice and this hospice is a Freestanding Hospice. It is located at 190 Old Derby Street Suite 304 in Hingham, Massachusetts. You can reach out to the office of New England Hospice Ii, Llc via phone at (781) 749-2900.

New England Hospice Ii, Llc is first approved in April, 2005 to provide medicare and/or medicaid services and its CMS certification number (CCN) is 221563. Boston is the CMS Regional Office responsible for the certification of this hospice.

Contact Information


New England Hospice Ii, Llc
190 Old Derby Street Suite 304, Hingham, MA, 02043
(781) 749-2900

News Archive

New MRI computing technique can measure strain in the heart without damaging kidneys

3D MRI computing can measure strain in the heart using image registration method. Traditional method involves giving the patient a dose of gadolinium which can affect the kidney, researchers at WMG, University of Warwick have found.

ACT's hESC-derived RPE cells receive EMA positive opinion for Orphan Drug Designation for Stargardt's disease

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT's human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells for designation as an orphan medicinal product for the treatment of Stargardt's disease.

Novel peptide-drug conjugate enhances the efficacy of immunotherapy in preclinical cancer models

A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint inhibitors in preclinical cancer models, according to results presented at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, held October 7-10, 2021.

Breaking the barriers for transgender health care

Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the field of transgender medicine.

Read more Medical News

› Verified 4 days ago

Map and Direction



Hospice Profile

NameNew England Hospice Ii, Llc
Location190 Old Derby Street Suite 304, Hingham, Massachusetts
Hospice ID221563
CategoryFreestanding Hospice
Ownership TypeProprietary - Other
Profit TypeFOR PROFIT
Accreditation ProviderThe Joint Commission (TJC)
SSA county code150

News Archive

New MRI computing technique can measure strain in the heart without damaging kidneys

3D MRI computing can measure strain in the heart using image registration method. Traditional method involves giving the patient a dose of gadolinium which can affect the kidney, researchers at WMG, University of Warwick have found.

ACT's hESC-derived RPE cells receive EMA positive opinion for Orphan Drug Designation for Stargardt's disease

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT's human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells for designation as an orphan medicinal product for the treatment of Stargardt's disease.

Novel peptide-drug conjugate enhances the efficacy of immunotherapy in preclinical cancer models

A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint inhibitors in preclinical cancer models, according to results presented at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, held October 7-10, 2021.

Breaking the barriers for transgender health care

Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the field of transgender medicine.

Read more Medical News

› Verified 4 days ago

NPI associated with this Hospice

A hospice usually have one NPI number but sometimes it may have multiple NPI numbers. We have found possible NPI number/s associated with New England Hospice Ii, Llc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1083199749
Organization NameNew England Hospice
Address190 Old Derby St Ste 304 Hingham, Massachusetts, 02043
Phone Number(781)749-2900

News Archive

New MRI computing technique can measure strain in the heart without damaging kidneys

3D MRI computing can measure strain in the heart using image registration method. Traditional method involves giving the patient a dose of gadolinium which can affect the kidney, researchers at WMG, University of Warwick have found.

ACT's hESC-derived RPE cells receive EMA positive opinion for Orphan Drug Designation for Stargardt's disease

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT's human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells for designation as an orphan medicinal product for the treatment of Stargardt's disease.

Novel peptide-drug conjugate enhances the efficacy of immunotherapy in preclinical cancer models

A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint inhibitors in preclinical cancer models, according to results presented at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, held October 7-10, 2021.

Breaking the barriers for transgender health care

Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the field of transgender medicine.

Read more Medical News

› Verified 4 days ago


NPI Number1558496323
Organization NameNew England Hospice Ii Llc
Address190 Old Derby Street Hingham, Massachusetts, 02043
Phone Number(781)749-2900

News Archive

New MRI computing technique can measure strain in the heart without damaging kidneys

3D MRI computing can measure strain in the heart using image registration method. Traditional method involves giving the patient a dose of gadolinium which can affect the kidney, researchers at WMG, University of Warwick have found.

ACT's hESC-derived RPE cells receive EMA positive opinion for Orphan Drug Designation for Stargardt's disease

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT's human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells for designation as an orphan medicinal product for the treatment of Stargardt's disease.

Novel peptide-drug conjugate enhances the efficacy of immunotherapy in preclinical cancer models

A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint inhibitors in preclinical cancer models, according to results presented at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, held October 7-10, 2021.

Breaking the barriers for transgender health care

Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the field of transgender medicine.

Read more Medical News

› Verified 4 days ago


Quality of Patient Care at New England Hospice Ii, Llc

Hospice staff should discuss treatment preferences and patient beliefs and values with patients and/or caregivers. They should also identify and provide interventions to address pain, shortness of breath and constipation (caused by opioids) to improve patient comfort and quality of life. New England Hospice Ii, Llc has the following score in these measures of patient care.
Better than National Average Worse than National Average

Quality MeasureProvider ScoreNational Score
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care99.598.3
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care99.593.6
Patients who were checked for pain at the beginning of hospice care99.593.9
Patients who got a timely and thorough pain assessment when pain was identified as a problem95.577.7
Patients who were checked for shortness of breath at the beginning of hospice care100.097.3
Patients who got timely treatment for shortness of breath98.094.6
Patients taking opioid pain medication who were offered care for constipation100.093.3

News Archive

New MRI computing technique can measure strain in the heart without damaging kidneys

3D MRI computing can measure strain in the heart using image registration method. Traditional method involves giving the patient a dose of gadolinium which can affect the kidney, researchers at WMG, University of Warwick have found.

ACT's hESC-derived RPE cells receive EMA positive opinion for Orphan Drug Designation for Stargardt's disease

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT's human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells for designation as an orphan medicinal product for the treatment of Stargardt's disease.

Novel peptide-drug conjugate enhances the efficacy of immunotherapy in preclinical cancer models

A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint inhibitors in preclinical cancer models, according to results presented at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, held October 7-10, 2021.

Breaking the barriers for transgender health care

Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the field of transgender medicine.

Read more Medical News

› Verified 4 days ago


Services Provided by New England Hospice Ii, Llc:

Hospice provide various services either through their own staff or through third-party arrangements. Find the list of services provided by New England Hospice Ii, Llc below:
  • By staff
    • Home Health Aide Service
    • Counseling Service
    • Medical Social Service
    • Nursing Service

  • Under Arrangement
    • Home Maker Service
    • Medical Supply Service
    • Occupational Therapy
    • Physician Service
    • Physical Therapy
    • Short Term Inpatient care
    • Speech Pathology

  • Combination of Staff and Under Arrangement
    • No services

  • Type of Short Term Inpatient Care
    • Acute and Respite

Number of Full-time equivalent Employees:

Number of full time equivalent employees at New England Hospice Ii, Llc
Home Health Aides5.93
Counselors2.29
Licensed Practical or Vocational Nurses1.82
Medical Social Workers 6.08
Registered Nurses11.72
Other Personnel9.53
Total Employees37.37

News Archive

New MRI computing technique can measure strain in the heart without damaging kidneys

3D MRI computing can measure strain in the heart using image registration method. Traditional method involves giving the patient a dose of gadolinium which can affect the kidney, researchers at WMG, University of Warwick have found.

ACT's hESC-derived RPE cells receive EMA positive opinion for Orphan Drug Designation for Stargardt's disease

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT's human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells for designation as an orphan medicinal product for the treatment of Stargardt's disease.

Novel peptide-drug conjugate enhances the efficacy of immunotherapy in preclinical cancer models

A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint inhibitors in preclinical cancer models, according to results presented at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, held October 7-10, 2021.

Breaking the barriers for transgender health care

Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the field of transgender medicine.

Read more Medical News

› Verified 4 days ago


Number of Full-time equivalent Volunteers:

Others2
Total Volunteers2

News Archive

New MRI computing technique can measure strain in the heart without damaging kidneys

3D MRI computing can measure strain in the heart using image registration method. Traditional method involves giving the patient a dose of gadolinium which can affect the kidney, researchers at WMG, University of Warwick have found.

ACT's hESC-derived RPE cells receive EMA positive opinion for Orphan Drug Designation for Stargardt's disease

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT's human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells for designation as an orphan medicinal product for the treatment of Stargardt's disease.

Novel peptide-drug conjugate enhances the efficacy of immunotherapy in preclinical cancer models

A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint inhibitors in preclinical cancer models, according to results presented at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, held October 7-10, 2021.

Breaking the barriers for transgender health care

Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the field of transgender medicine.

Read more Medical News

› Verified 4 days ago

Certification Details for New England Hospice Ii, Llc:

  • May, 2017 is the initial visit of the health survey for certifications by CMS.
  • It is in compliance at the time of certification survey by CMS.
  • It is eligible to participate in the medicare and/or medicaid program.
  • National Heritage (hha - A) is the Medicare Administrative Contractor (MAC), intermediary or carrier servicing this hospice.
  • Current status is Active Provider.
  • Reason of certification is Recertification.
  • End of fiscal year is on 31, December.

Hospices in Hingham

New England Hospice Ii, Llc
Location: 190 Old Derby Street Suite 304, Hingham, Massachusetts, 02043
Phone: (781) 749-2900

Medicare Hospice Care

What is Hospice Care?
Hospice care is a type of care and philosophy of care that focuses on the palliation of a chronically ill, terminally ill or seriously ill patient's pain and symptoms, and attending to their emotional and spiritual needs. Care may be provided in a patient's home or in a designated facility such as nursing home, hospital unit or freestanding hospice, with level of care and sometimes location based upon frequent evaluation of the paients needs. The four primary levels of care provided by hospice are routine home care, continuous care, general inpatient and respite care.

How long can one get medicare hospice care?
Hospice care is for people with a life expectancy of 6 months or less (if the disease runs its normal course). If the person receiving hospice care live longer than 6 months, he or she can still get hospice care.
  • A person can get hospice care for two 90-day benefit periods, followed by an unlimited number of 60-day benefit periods.
  • At the start of each period, the hospice medical director or other hospice doctor must recertify that the person is terminally ill (with a life expectancy of 6 months or less). This step is must for continued hospice care.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.